Legal Opinion
Novartis Ag v. Focarino
Court of Appeals for the Federal Circuit
Decided January 15, 2014No. 20-1724PublishedCited by 16 opinions
1Opinion of the Court
TARANTO, Circuit Judge.
Novartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. § 154(b), to the otherwise-applicable term of various Novartis patents. Of the eighteen patents before us, the district court dismissed Novartis’s claims regarding fifteen as untimely asserted. For the other three, the court rejected the PTO’s construction of the statutory provision that governs patent term adjustment here.
We affirm the district…
2Cases cited7 opinions
- Holland v. FloridaSupreme Court of the United States · 2010
- West Virginia University Hospitals, Inc. v. CaseySupreme Court of the United States · 1991
- United States v. LockeSupreme Court of the United States · 1985
- Wyeth v. KapposCourt of Appeals for the Federal Circuit · 2010
- Venture Coal Sales Company, Sanner Energies, Inc., and Future Industries, Inc. v. United StatesCourt of Appeals for the Federal Circuit · 2004
2 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Carson Optical Inc. v. eBay Inc.District Court, E.D. New York · 2016
- Supernus Pharmaceuticals, Inc. v. IancuCourt of Appeals for the Federal Circuit · 2019
- Nippon Shinyaku Co. v. IancuCourt of Appeals for the D.C. Circuit · 2019
- Intra-Cellular Therapies, Inc v. IancuCourt of Appeals for the Federal Circuit · 2019
- Daiichi Sankyo Company v. LeeCourt of Appeals for the Federal Circuit · 2015
11 more not listed; retrieve them via the Exa API.